Murielle Baltazar

Liverpool, ENG L697BE, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Hypervirulent serotype 1 pneumococci display high levels of nasal shedding and rapid onward transmission.

Hypervirulent serotype 1 pneumococci display high levels of nasal shedding and rapid onward transmission.

Journal: The Journal of infection
Published: July 29, 2025

The Streptococcus agalactiae LytSR two-component regulatory system promotes vaginal colonization and virulence in vivo.

The Streptococcus agalactiae LytSR two-component regulatory system promotes vaginal colonization and virulence in vivo.

Journal: Microbiology spectrum
Published: October 14, 2024

Nasal delivery of killed Bacillus subtilis spores protects against influenza, RSV and SARS-CoV-2.

Nasal delivery of killed Bacillus subtilis spores protects against influenza, RSV and SARS-CoV-2.

Journal: Frontiers in immunology
Published: September 25, 2024

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.

Journal: Scientific reports
Published: April 13, 2023

Influence of Streptococcus pneumoniae Within-Strain Population Diversity on Virulence and Pathogenesis.

Influence of Streptococcus pneumoniae Within-Strain Population Diversity on Virulence and Pathogenesis.

Journal: Microbiology spectrum
Published: December 12, 2022

Streptococcus pneumoniae Rapidly Translocate from the Nasopharynx through the Cribriform Plate to Invade the Outer Meninges.

Streptococcus pneumoniae Rapidly Translocate from the Nasopharynx through the Cribriform Plate to Invade the Outer Meninges.

Journal: mBio
Published: August 04, 2022

Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.

Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.

Journal: Scientific reports
Published: March 25, 2022

Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection.

Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection.

Journal: Scientific reports
Published: April 25, 2021

Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.

Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.

Journal: Scientific reports
Published: March 18, 2021

Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.

Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.

Journal: Scientific reports
Published: June 09, 2020

Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin.

Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin.

Journal: Nature communications
Published: January 22, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026